Skip to main content
. Author manuscript; available in PMC: 2021 Oct 6.
Published in final edited form as: Mol Pharm. 2017 Feb 3;14(5):1384–1394. doi: 10.1021/acs.molpharmaceut.6b01005

Table 4.

Multiblock Degradable Conjugates for PK Studies

conjugate Mw (kDa) PDI drug (%)
GEM mP–GEM300 330 1.18 9.2
mP–GEM200 227 1.25 7.6
2P–GEM 127 1.21 10.1
P–GEMa 32 1.05 8.2
PTX mP–PTX200 240 1.18 6.5
2P–PTX 119 1.20 6.3
P–PTXa 48 1.05 7.3
a

From ref 19.